Cullinan Therapeutics, Inc. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Theravance Biopharma, Inc.

SIGA Technologies, Inc.

Liquidia Corp.

Zymeworks, Inc.

Marinus Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.

Oculis Holding AG

Cullinan Therapeutics, Inc.

Icosavax, Inc.

Biomea Fusion, Inc.

Procaps Group SA

Why is Cullinan Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Cullinan Therapeutics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Cullinan Therapeutics, Inc.

42.67%

-0.57

77.78%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-236.16%

EBIT to Interest (avg)

-139.49

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.55

Sales to Capital Employed (avg)

0.04

Tax Ratio

0.07%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

ROE (avg)

2.63%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.88

EV to EBIT

-2.14

EV to EBITDA

-2.15

EV to Capital Employed

4.32

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-201.26%

ROE (Latest)

-48.03%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

NET PROFIT(HY)

Higher at USD -120.67 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-10What is not working for the Company

NET PROFIT(HY)

At USD -120.67 MM has Grown at -46.1%

OPERATING CASH FLOW(Y)

Lowest at USD -174.28 MM

ROCE(HY)

Lowest at -40.18%

Here's what is working for Cullinan Therapeutics, Inc.

Net Profit

Higher at USD -120.67 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Cullinan Therapeutics, Inc.

Net Profit

At USD -120.67 MM has Grown at -46.1%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow

Lowest at USD -174.28 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)